SAHPRA warns against use of diabetes drugs for weight loss
The South African Health Products Regulatory Authority (SAHPRA) is urging South Africans trying to lose weight to refrain from using Ozempic and Mounjaro as they are not approved for weight management in the country. The concern comes amid a rapid increase in the sale and presence of counterfeit Glucagon-like Peptide (GLP-1) products, such as Ozempic, on the local market. While the drugs are mostly used to help lower blood sugar […]